1 document found, page 1 of 1
Sort by
Issue Date
Remission and low disease activity matrix tools: results in real-world rheumato...
Ganhão, S; Lucas, R; Fonseca, JE; Santos, MJ; Gonçalves, DR; Madeira, N; Silva, C; Dourado, E; Freitas, R; Rodrigues, J; Azevedo, S; Rocha, TMBackground: Remission/ low disease activity (LDA) are the main treatment goals in rheumatoid arthritis (RA) patients. Two tools showing the ability to predict golimumab treatment outcomes in patients with RA were published. Objectives: To estimate the real-world accuracy of two quantitative tools created to predict RA remission and low disease activity. Methods: Multicenter, observational study, using data from...
Date: 2020
|
Origin: Repositório Aberto da Universidade do Porto